IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v619y2023i7970d10.1038_s41586-023-06364-2.html
   My bibliography  Save this article

Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Author

Listed:
  • Susan Wyllie

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Michael Thomas

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Stephen Patterson

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Sabrinia Crouch

    (Global Health R&D, GlaxoSmithKline)

  • Manu Rycker

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Rhiannon Lowe

    (David Jack Centre for R&D, GlaxoSmithKline)

  • Stephanie Gresham

    (David Jack Centre for R&D, GlaxoSmithKline)

  • Michael D. Urbaniak

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee
    Faculty of Health and Medicine, Lancaster University)

  • Thomas D. Otto

    (Wellcome Sanger Institute
    Centre of Immunobiology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow)

  • Laste Stojanovski

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Frederick R. C. Simeons

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Sujatha Manthri

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Lorna M. MacLean

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Fabio Zuccotto

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Nadine Homeyer

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Hannah Pflaumer

    (Cellzome GmbH, A GlaxoSmithKline Company)

  • Markus Boesche

    (Cellzome GmbH, A GlaxoSmithKline Company)

  • Lalitha Sastry

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Paul Connolly

    (GlaxoSmithKline, New Frontiers Science Park)

  • Sebastian Albrecht

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Matt Berriman

    (Wellcome Sanger Institute)

  • Gerard Drewes

    (Cellzome GmbH, A GlaxoSmithKline Company)

  • David W. Gray

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Sonja Ghidelli-Disse

    (Cellzome GmbH, A GlaxoSmithKline Company)

  • Susan Dixon

    (Global Health R&D, GlaxoSmithKline, Stockley Park West)

  • Jose M. Fiandor

    (Global Health R&D, GlaxoSmithKline)

  • Paul G. Wyatt

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Michael A. J. Ferguson

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Alan H. Fairlamb

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Timothy J. Miles

    (Global Health R&D, GlaxoSmithKline)

  • Kevin D. Read

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

  • Ian H. Gilbert

    (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee)

Abstract

No abstract is available for this item.

Suggested Citation

  • Susan Wyllie & Michael Thomas & Stephen Patterson & Sabrinia Crouch & Manu Rycker & Rhiannon Lowe & Stephanie Gresham & Michael D. Urbaniak & Thomas D. Otto & Laste Stojanovski & Frederick R. C. Simeo, 2023. "Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis," Nature, Nature, vol. 619(7970), pages 48-48, July.
    • Handle: RePEc:nat:nature:v:619:y:2023:i:7970:d:10.1038_s41586-023-06364-2
    DOI: 10.1038/s41586-023-06364-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-023-06364-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-023-06364-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:619:y:2023:i:7970:d:10.1038_s41586-023-06364-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.